Background. The acute phase of mycobacterial lung infection is characterized by a nearly exponential outgrowth of mycobacteria in the alveolar airspace and lung parenchymal tissue, suggesting insufficient early protective immunity against mycobacterial challenge. In the current study, we tested the hypothesis that a CC chemokine ligand 2 (CCL2)-dependent increased mononuclear phagocyte subset accumulation in distal airspaces would improve the lungs' protective immunity to infection with Mycobacterium bovis bacille Calmette-Guérin (hereafter, "M. bovis BCG").
infection with M. bovis BCG. First, apoptosis-induced loss of the phagocyte subsets involved in mycobacterial pathogen uptake (alveolar and lung macrophages and DCs) might be compensated more efficiently. Second, increased mycobacterial pathogen uptake by conventional DCs and their transportation into lung-draining lymph nodes (dLNs) may accelerate T cell-dependent adaptive immune responses in the lungs. Finally, increases in the size of the mononuclear phagocyte pool in the lungs may be important to restrict mycobacteria-induced lung immunopathology.
The monocyte chemoattractant CC chemokine ligand 2 (CCL2), which binds to and signals through its receptor, CCR2, is known to elicit inflammatory monocyte recruitment toward the lungs of mice [5, 6] . Inflammatory monocyte subsets thus recruited give rise to the various mononuclear phagocyte subsets (alveolar and lung macrophages, exudate macrophages, and conventional DCs) that accumulate in the lungs of mice in response to inflammation and infection [6 -11] . In the current study, we hypothesized that a CCL2-dependent increase in the size of the lungs' mononuclear phagocyte pool during the initial phase of mycobacterial infection improves protective immune responses to infection with M. bovis BCG. To test this hypothesis, wild-type mice and CCL2-overexpressing mice that exhibited increased pools of alveolar and lung mononuclear phagocytes-due to lung-specific overexpression of human CCL2 in type-II alveolar epithelial cells-were infected intratracheally with M. bovis BCG and the developing lung inflammatory response was analyzed.
METHODS

Animals.
Female CCL2-overexpressing mice that harbored an endogenous human ccl2 transgene under control of the surfactant protein C promoter expressed only by type-II alveolar epithelial cells in the transgenic mice were generated as described elsewhere and backcrossed 8 generations onto the BALB/c background [12] . Female wild-type BALB/c mice were used as controls. All mice used were 8 -12 weeks of age. Animal experiments were approved by our local government authorities.
Reagents. The antibodies employed in the current study for fluorescence-activated cell sorter (FACS) analysis of mononuclear phagocyte subsets were from BD Biosciences or Serotec. The magnetic-activated cell sorting kit and CD11c beads were purchased from Miltenyi Biotec. The red fluorescent dye PKH26-GL and the diluent C were purchased from Sigma.
Culture and labeling of M. bovis BCG. M. bovis BCG (strain Pasteur) was cultured in Middlebrook 7H9 medium until mid-log phase [3] . Thereafter, the culture was harvested and the suspension was frozen in 1-mL aliquots at Ϫ80°C until use. To calculate the number of colony-forming units, aliquots were serially diluted in Middlebrook 7H9 medium and plated on 7H10 agar plates, followed by determination of the number of colonyforming units after 3 weeks of incubation at 37°C. To track the movement of M. bovis BCG -phagocytosing DCs towards dLNs, in selected experiments CCL2-overexpressing mice were infected with mycobacteria that were prelabeled with the red fluorescent dye PKH26-GL, as in detail described elsewhere [3] .
Infection of mice. Wild-type mice and CCL2-overexpressing mice were administered a low dose M. bovis BCG infection (3 ϫ 10 5 cfu/mouse) via intratracheal instillation, as described elsewhere [3] .
Bronchoalveolar lavage and preparation of lung parenchymal and spleen tissue and dLNs. BAL was performed as described elsewhere [3, 7, 8] . Cells obtained by BAL were counted and then lysed in 0.1% saponin in PBS (pH 7.2) for 8 min at 37°C. Cell lysates were plated in 10-fold serial dilutions on 7H10 agar plates, which were subsequently incubated at 37°C for 3 weeks, followed by a count of colony-forming units.
The lung lobes were carefully isolated while avoiding contamination from the conducting airway or dLNs. Lung and spleen tissue were homogenized separately by using a tissue homogenizer (IKA), and 10-fold serial dilutions of saponin-pretreated (0.1% saponin in PBS, pH 7.2) lung tissue or spleen homogenates were plated on 7H10 agar plates for a count of colonyforming units [3] . The number of colony-forming units in dLNs were determined by careful disruption of isolated lymph nodes with sterile forceps, followed by incubation of lymph-node tissue in 0.1% saponin (10 min at 37°C), and plating of 10-fold serial dilutions of lymph-node lysates on 7H10 agar plates for 3 weeks at 37°C. pos DCs), as described elsewhere [7, 9, 13] . Quantification of neutrophils and lymphocytes from BAL fluid was done with differential cell counts of Pappenheim-stained cytocentrifuge preparations, and subsequent multiplication of those values by the respective absolute counts of cells obtained by BAL.
Lung lobes were processed for isolation of CD11c pos lung parenchymal mononuclear phagocytes, as described elsewhere [3, 13] . Subsequently, purified cells were preincubated with human IgG (Octagam; Octapharma) and then stained for 15 min at 4°C with various combinations of fluorochrome-conjugated monoclonal antibodies with specificities for the following cell-surface molecules: peridinin-chlorophyll-protein complex-Cy5.5-conjugated anti-CD11b, phycoerythrin (PE)-Cy5.5-or allophycocyanin (APC)-conjugated anti-CD11c, PE-conjugated anti-CD49d, PE-conjugated anti-CD86, fluorescein isothiocyanate (FITC)-or PE-conjugated anti-MHC II antibody (all from BD Biosciences), and APC-conjugated anti-F4/80 (Serotec). Subsequently, cells were washed in a solution of PBS, bovine serum albumin (0.1%), and sodium azide (0.02%) and analyzed on a 2-laser BD FACSCanto flow cytometer (BD Biosciences).
Real-time reverse-transciptase polymerase chain reaction (RT-PCR). Real-time RT-PCR analysis of nitric oxide synthase 2 (NOS2) gene expression in lung-tissue lysates from untreated and M. bovis BCG-infected wild-type and CCL2-transgenic mice was done essentially as described elsewhere [3] . NOS2 primers are accessible via the Real-Time Primer and Probe database (no. 3484; http://medgen.ugent.be/rtprimerdb/) [14] . Primer sequences for housekeeping gene ␤-actin were as follows: forward, 5'-CCACAGCTGAGAGGGAAATC-3' and reverse, 5'-TCTCCAG-GGAGGAAGAGG AT-3' [15] .
Lung histopathology. Histopathological examination of lung tissue sections (5 m) from wild-type mice and CCL2-overexpressing mice was done by using a Zeiss Axiovert 200 M microscope (Zeiss) [9] .
Statistics. All data are given as mean Ϯ SD. Differences between control animals and the various treatment groups over time were analyzed by analysis of variance, followed the by post hoc Dunnett test. Significant differences between the groups were analyzed using SPSS for Windows, by Levene's test for equality of variances, followed by the Student's t test. Significant differences between treatment groups were assumed when P values were Ͻ.05.
RESULTS
Effect of CCL2 overexpression on cellular constituents of BAL fluid. We first characterized the cellular constituents of BAL fluid from the lungs of mock-infected (i.e., uninfected) CCL2-transgenic and mock-infected wild-type mice. Uninfected CCL2-transgenic mice demonstrated a significant increase in the total number of cells in BAL fluids, compared with wild-type mice, consistent with recent reports [9] . FACS analysis of the cellular constituents of BAL fluid revealed that, in particular, the numbers of alveolar macrophages, exudate mononuclear phagocytes, and lymphocytes, but not neutrophils, were significantly increased in mock-infected, transgenic mice, compared with controls (figure 1A-E). According to recent reports, exudate mononuclear phagocytes were mainly composed of alveolar DCs and, to a lesser degree, of alveolar monocytic cells [9] , whereas lymphocyte subset-specific FACS analysis revealed a predominance of CD4 pos T cells (Ͼ50%); in this subset, CD8 pos T cells amounted to approximately 10%-20% of total lymphocytes, and CD19 pos B cells amounted to Ͻ5%-10% of total lymphocytes at all time points investigated (data not shown in detail).
In response to infection with M. bovis BCG, total cell numbers in BAL fluid were particularly increased in M. bovis BCG-infected, CCL2-transgenic mice, mainly due to increased numbers of exudate phagocytes, which did not increase in M. bovis BCGinfected wild-type mice ( figure 1A and 1C ). In addition, BCG infection in CCL2-transgenic mice significantly increased the numbers of alveolar-accumulating CD4 pos and CD8 pos T cells (40%-60% and 10%-25%, respectively), compared with BCGinfected wild-type mice (figure 1E), whereas the increased numbers of alveolar macrophages noted in CCL2-overexpressing mice did not increase in response to mycobacterial challenge (figure 1B figure 2E ). In CCL2-transgenic mice, lung DCs had a similar immunophenotype as those in wild-type mice (P2 in figure 2H-J and 2L). However, green-autofluorescent lung macrophages from CCL2-transgenic mice were found to consist of both "classical" lung macrophages (CD11b neg /MHCII neg-low /CD86 neg ) (P3-1 in figure 2K and 2L) and a second subset of lung macrophages (CD11b pos / MHCII neg-low /CD86 neg-low ) (P3-2 in figure 2K and 2L), which, according to their antigenic profile, represent lung exudate macrophages that are recruited into the lungs as a consequence of CCL2 transgene expression (figure 2G-L). On the basis of this analysis, uninfected CCL2-transgenic mice demonstrated significantly increased numbers of lung macrophages, lung exudate macrophages, and lung DCs, compared with uninfected wild-type mice (figure 3). During mycobacterial infection, these major lung parenchymal mononuclear phagocyte subsets further increased in size in CCL2-overexpressing mice, whereas in wild-type mice, de novo recruitment of lung exudate macrophages and lung DCs occurred only at day 28 after infection ( figure 3A-C) .
Effect of lung-specific CCL2 overexpression in mice on mycobacterial pathogen elimination. CCL2-overexpressing mice showed significantly decreased mycobacterial loads both in the bronchoalveolar and lung parenchymal compartment when compared with M. bovis BCG-infected wild-type mice ( figure  4A and 4B ). Transgenic mice also demonstrated higher myco-CCL2 in Mycobacterial Infection • JID 2008:198 (1 October) • 3 bacterial loads in their dLNs, compared with wild-type mice, at least until day 28 after infection, at which time mycobacterial loads began to drop in both experimental groups (figure 4C). However, on days 7 and 28 after infection, mycobacterial loads were significantly lower in the spleens of CCL2-transgenic mice compared with the bacterial load in the spleens of wild-type mice, suggesting that CCL2 overexpression also reduces dissemination of mycobacteria into other organ systems such as the spleen ( figure 4D ). In contrast, mycobacterial loads in the liver of transgenic and wild-type mice were below the limit of detection (data not shown). Interestingly, real-time RT-PCR analysis of NOS2 expression revealed a similar baseline NOS2 mRNA in the lung tissue of mice from both treatment groups, whereas transgenic mice responded with 8-fold increase in NOS2 mRNA levels on day 14 after infection (relative to levels in wild-type mice), with a rapid decline by day 28 after infection. However, immunohistochemical analysis of NOS2 protein in lung tissue sections did not reveal overt differences between groups (data not shown).
Effect of lung-specific CCL2 overexpression on M. bovis BCGinduced lung granuloma formation and resolution. Histopathology of lung sections from uninfected CCL2-transgenic and wild-type mice revealed normal lung architecture with no differences between groups ( figure 5A and 5B). In response to M. bovis BCG infection, lung granulomas formed both in the perivascular and peribronchial compartment in CCL2-transgenic and wildtype mice by day 14 after infection, being more accentuated in the transgenic mice ( figure 5A ). Peak lung granuloma induction and extension towards the lung interstitial compartments and the beginning of lung-tissue necrosis associated with neutrophilic responses was observed on day 28 after infection and was more pronounced in M. bovis BCG-infected, CCL2-transgenic mice, compared with wild-type mice ( figure 5A and 5B). At the same time, acid-fast bacilli were more frequently observed in Ziehl-Neelsen-stained sections of lung tissue from wild-type mice, compared with transgenic mice, at day 28 after infection (figure 5C), consistent with the data in figure 4 . By day 56 after infection, a strong decline in the number of lung granulomas in the CCL2-overexpressing mice but not in wild-type mice infected with M. bovis BCG was noted, which coincided with the aforementioned drop in colony-forming units at that time point, particularly in the transgenic mice (compare with figure 4 ). These data illustrate that CCL2-overexpressing mice demonstrated improved elimination of mycobacterial pathogens in the lung compartments examined and an accelerated induction and resolution of lung granuloma formation in response to mycobacterial infection, compared with wild-type mice. 
Effect of CCL2 overexpression on the mobilization of DCs into dLNs in response to infection.
To investigate whether the increased numbers of alveolar and lung parenchymal DCs observed in M. bovis BCG-infected, CCL2-overexpressing mice would contribute to increased shuttling of mycobacteria from peripheral lung compartments into dLNs, we quantified DC numbers and mycobacterial loads in the dLNs of mice from both treatment groups. DCs in dLNs were identified according to their CD3 neg /CD11c high /CD11b high /MHCII high immunophenotypic profile ( figure 6 A-C) . CCL2-overexpressing mice demonstrated increased numbers of both DCs and CD3 pos lymphocytes in their dLN baseline counts and in response to mycobacterial infection, compared with wild-type mice, with significant differences noted between groups on days 14 and 28 after infection (figure 6E and 6F)-the time points at which bacterial loads in the dLNs of CCL2-overexpressing mice reached their maximum ( figure 4C) . Importantly, DCs of CCL2-overexpressing mice infected with PKH26-prelabeled M. bovis BCG demonstrated a detectable increase in red fluorescence emission when compared with DCs from uninfected transgenic mice or DCs from transgenic mice infected with unlabeled BCG for 28 days ( figure 6D and data not shown). These data support the concept that increased mycobacterial loads in dLNs of CCL2-overexpressing mice may have developed, at least in part, from an increased amount of DC shuttling of mycobacteria from the alveolar and lung parenchymal compartments toward the dLNs and from the Figure 3 . Effect of CC chemokine ligand 2 (CCL2) overexpression in mice on changes in lung mononuclear phagocyte subset accumulation profiles in response to lung mycobacterial infection. CCL2-overexpressing mice (black bars) and wild-type mice (white bars) were either mock-infected or infected with Mycobacterium bovis bacille Calmette-Guérin. Subsequently, mice were euthanized at the indicated time points and subjected to purification and quantification of the lung mononuclear phagocyte subsets in their lung parenchymal tissues. Values are mean Ϯ SD for 5-6 mice per time point for each treatment group. *P Ͻ .05, **P Ͻ .03-significant difference in comparison with wild-type mice. ϩϩ P Ͻ .03, ϩϩϩP Ͻ .001-significant difference in comparison with the relevant control values (day 0).
fact that CCL2 overexpression leads to an accelerated execution of adaptive immune responses in the transgenic mice.
DISCUSSION
In the present study, we show that CCL2-overexpressing micecharacterized by a constitutively increased mononuclear phagocyte subset accumulation in their lungs and dLNs-responded to infection with M. bovis BCG with both a significantly increased alveolar and lung exudate mononuclear phagocyte subset and lymphocyte recruitment. Moreover, CCL2-overexpressing mice demonstrated significantly reduced mycobacterial loads in the bronchoalveolar and lung parenchymal compartment, as well as the spleen, compared with wild-type mice infected with M. bovis BCG, and showed an increased trafficking of mycobacteria-loaded DCs into dLNs. In addition, both induction and resolution of lung granuloma formation were more accelerated in CCL2-overexpressing mice, compared with wild-type mice infected with M. bovis BCG. Thus, the data of the current study show that a CCL2-dependent increased mobilization of lung mononuclear phagocyte and lymphocyte subsets during the acute phase of mycobacterial infection may be beneficial for host defense in the lung against mycobacterial infections and the dissemination of this infection into other organs.
Professional phagocytes of the lung, such as alveolar and lung macrophages, as well as conventional CD11b pos lung DCs, are considered to be the primary target cells involved in early mycobacterial pathogen uptake and antigen processing [3] . In the cur- rent study, the number of exudate macrophages and lung DCsbut not alveolar macrophages-was strongly increased in CCL2-overexpressing mice relative to wild-type mice when these groups of mice were infected with mycobacteria. Mycobacterial uptake by mononuclear phagocytes was recently found to occur as early as 6 h after mycobacterial infection and was significantly enhanced in mice previously immunized with M. bovis BCG [3] . Because mycobacterial infection is known to cause apoptosis in Figure 5 . Lung histopathology in CC chemokine ligand 2 (CCL2)-overexpressing mice and wild-type mice infected with Mycobacterium bovis bacille Calmette-Guérin (M. bovis BCG). CCL2-overexpressing mice and wild-type mice were either mock-infected or received intratracheal instillations of M. bovis BCG. At the indicated time points, mice were euthanized, whole lungs were removed, and lung tissue sections (5 m) were prepared for lung morphometric examination (A) and histopathologic examination (B). C, Representative Ziehl-Neelsen stain of lung tissue sections of wild-type mice and CCL2-transgenic mice at day 28 after infection. Arrows point to acid-fast bacilli. Data in A are mean Ϯ SD for 3-5 mice per time point and from each treatment group. **P Ͻ .03-significant decrease, compared with wild-type mice. Photographs are 2.5ϫ (B) or 40ϫ (C) original magnification.
macrophages [2] , inflammatory CCL2-dependent monocyte and/or macrophage mobilization into the lung appears to be indispensable for the maintenance of the lungs' protective immunity to inhaled mycobacterial pathogens, including M. bovis BCG [4] . As such, the data presented here demonstrate that CCL2-dependent accumulation of mononuclear phagocyte subsets strongly improves host defense in the lung against mycobacterial infections, supporting the concept that CCL2 is involved in chemoattracting those cells that form lung granulomas in mice in response to mycobacterial challenge, as well as in response to nonspecific stimuli such as yeast-wall glucan [12] . Taken together with the observation that mice lacking the primary CCL2 receptor, CCR2, are highly susceptible to mycobacterial infection, the relevance of the CCL2-CCR2 axis in antimycobacterial host defense becomes even more evident [1, 10, 16, 17] .
Several facts may account for the improved antimycobacterial host response observed in the CCL2-overexpressing mice infected with M. bovis BCG. First, CCL2-overexpressing mice showed increased mononuclear phagocyte subset accumulation in all lung compartments investigated (including dLNs), both constitutively and in response to mycobacterial infection, which may facilitate an improved immune surveillance in the lung. Importantly, CCL2-transgenic mice had delayed dissemination and lower levels of dissemination of mycobacteria into their spleen, compared with wild-type mice. Values in E and F are mean Ϯ SD for 5-7 mice per time point for each treatment group. **P Ͻ .03, ***P Ͻ .01-significant difference compared to wild-type mice. ϩϩϩP Ͻ .001, significant difference compared to the respective mock (day 0) infection. PE, phycoerythrin.
tance to the facilitation of macrophage-dependent antimycobacterial responses [2, 18, 19] . Cumulatively, these data support the concept that enhanced drainage of M. bovis BCG to the dLNs of CCL2-transgenic mice via DCs, as evidenced by increased numbers of mycobacterial colony-forming units in dLNs early during infection, leads to an accelerated and enhanced priming and proliferation of T cells in this compartment, which subsequently orchestrate a more efficient killing of M. bovis BCG in all organs, including the dLNs [20] .
Thus, the data presented support the view that those antimycobacterial cellular-defense mechanisms (including macrophages, DCs, and T cells) that may determine a rapid and efficient protective immune response to mycobacterial infection were optimized, i.e., more rapidly and efficiently executed, in the CCL2-overexpressing mice, compared with wild-type mice, thus ultimately resulting in increased mycobacterial killing and an accelerated resolution of lung granuloma formation in these mice.
In addition to the important roles of mononuclear phagocyte and lymphocyte subsets in host antimycobacterial responses, the role of neutrophils in the host defense of the lungs against mycobacterial infections is still controversial. It has been shown recently that the depletion of neutrophils prolonged survival of susceptible mouse strains infected with M. tuberculosis [21] . In humans, most recent reports showed that the depletion of neutrophils impaired the capacity to restrict mycobacterial growth in whole-blood assays, suggesting that there is at least a contribution made by neutrophils to innate immune resistance against mycobacteria [22] . In the current study, we found that wild-type mice responded with a significantly increased neutrophil recruitment in the later phase of mycobacterial infection, compared with CCL2-overexpressing mice, while at the same time demonstrating increased mycobacterial loads in all of the lung compartments investigated, including the bronchoalveolar space, lung parenchymal tissue, and dLNs. These data challenge the capacity of neutrophils, as opposed to mononuclear phagocytes, at least in mice, to play a major role in the host defense in the lungs against mycobacterial infections.
In the current study, M. bovis BCG-infected, CCL2-overexpressing mice demonstrated significantly increased numbers of DCs in lung parenchymal tissue along with an increased appearance of mycobacteria-loaded DCs in dLNs, compared with wild-type mice, suggesting that CCL2 overexpression contributed to increased DC-dependent sampling of inhaled mycobacterial pathogens from intra-alveolar spaces and their transportation towards dLNs. This process also may have contributed to the accelerated lung granulomatous response in the transgenic mice, as compared with wild-type mice.
One unresolved aspect of the current study is whether the phagocyte subsets identified in the lungs of transgenic mice contribute equally to mycobacterial killing. As noted before, a drop in colony-forming units in the lungs of CCL2-transgenic mice may be due to increased DC-mediated sampling and/or transportation of mycobacteria to dLNs. However, a direct effect of the transgene expression on the killing capacity of lung mononuclear phagocytes cannot be excluded because CCL2 may also affect the activation status of and reactive oxygen species-formation by mononuclear phagocytes [23] [24] [25] .
Collectively, the data in the current study demonstrate that increased CCL2-dependent mobilization of lung sentinel cells may have the benefit of more efficiently purging mycobacterial infections in the lung. These data may be relevant for developing novel therapeutic interventions aimed at accelerating endogenous antimycobacterial host defense programs independent of antimycobacterial chemotherapy.
